Get started
Author

Ann Raftery

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
2016 · Payam Nahid, Susan E. Dorman, et al. · Clinical Infectious Diseases · 1,490
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
2019 · Payam Nahid, Sundari R. Mase, et al. · American Journal of Respiratory and Critical Care Medicine · 462
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
2016 · Payam Nahid, Susan E. Dorman, et al. · Clinical Infectious Diseases · 326
PDF
Linezolid in the Treatment of Multidrug‐Resistant Tuberculosis
2009 · G. F. Schecter, C. Scott, et al. · Clinical Infectious Diseases · 186
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease
2023 · Connie A Haley, Marcos C Schechter, et al. · Clinical Infectious Diseases · 50
PDF
Rapid Drug Susceptibility Testing with a Molecular Beacon Assay Is Associated with Earlier Diagnosis and Treatment of Multidrug-Resistant Tuberculosis in California
2010 · Ritu Banerjee, Jennifer Allen, et al. · Journal of Clinical Microbiology · 20
Outcomes and Treatment-limiting Adverse Events of Patients Receiving BPaL and BPaL-FQ in California
2026 · Shereen S Katrak, Rebecca C Wang, et al. · Open Forum Infectious Diseases
Education and Training Needs of U.S. Tuberculosis Programs
2025 · Allison Maiuri, Katharine Tatum, et al. · Health Promotion Practice
Works count: 9
Citation count: 2,534
H-index: 6
I10-index: 6
Year
Topic
Type